M. Scopinaro

发表

Results of a prospective study for the treatment of unilateral retinoblastoma

G. Chantada, P. Zubizarreta, A. Fandiño, 2010, Pediatric blood & cancer.

Treatment results in patients with retinoblastoma and invasion to the cut end of the optic nerve

M. D. de Dávila, G. Chantada, E. Vaiani, 2009, Pediatric blood & cancer.

Some Clinical Findings at Presentation Can Predict High-risk Pathology Features in Unilateral Retinoblastoma

M. D. de Dávila, D. Abramson, G. Chantada, 2009, Journal of pediatric hematology/oncology.

Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 study.

M. Stevens, A. Kelsey, J. Merks, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hepatocellular Carcinoma in Children: Does Modified Platinum- and Doxorubicin-Based Chemotherapy Increase Tumor Resectability and Change Outcome? Lessons Learned From the SIOPEL 2 and 3 Studies.

B. Morland, G. Perilongo, R. Kebudi, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.

G. Perilongo, A. Zimmermann, L. Brugières, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Infantile fibrosarcoma: management based on the European experience.

A. Ferrari, M. Carli, D. Orbach, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Infantile Fibrosarcoma: Management Based on the

A. Ferrari, M. Carli, D. Orbach, 2010 .

An Aggressive Bone Marrow Evaluation Including Immunocytology With GD2 for Advanced Retinoblastoma

M. D. de Dávila, J. Rossi, D. Abramson, 2006, Journal of pediatric hematology/oncology.

Colorectal Carcinoma in Children, Adolescents, and Young Adults

G. Chantada, E. G. Deza, F. G. Gercovich, 2005, Journal of pediatric hematology/oncology.

Outcome of patients with retinoblastoma and postlaminar optic nerve invasion.

M. D. de Dávila, G. Chantada, S. Galli, 2007, Ophthalmology.

No advantage of a rotational continuation phase in acute lymphoblastic leukemia in childhood treated with a BFM back‐bone therapy

J. Rossi, C. Alonso, M. Gallego, 2011, Pediatric blood & cancer.

Results of a randomized, prospective clinical trial evaluating metronomic chemotherapy in nonmetastatic patients with high‐grade, operable osteosarcomas of the extremities: A report from the Latin American Group of Osteosarcoma Treatment

Á. Atallah, A. Petrilli, M. T. Almeida, 2017, Cancer.

Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2.

G. Perilongo, L. Brugières, R. Rondelli, 2004, European journal of cancer.

Fever and neutropenia in children with cancer in one pediatric hospital in Argentina.

L. Casimir, R. Bologna, H. Paganini, 1998, Pediatric hematology and oncology.

Association of near-diploid DNA content and N-myc amplification in neuroblastomas

C. Dominici, G. Raschellà, F. Mauro, 1989, Clinical & Experimental Metastasis.

Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country

M. D. de Dávila, G. Chantada, S. Casak, 2005, Pediatric blood & cancer.

Importance of Multi-lineage Hematologic Involvement and Hypoalbuminemia at Diagnosis in Patients With “Risk-organ” Multi-system Langerhans Cell Histiocytosis

G. Chantada, B. Ozuna, J. Braier, 2010, Journal of pediatric hematology/oncology.

Phase II study of ifosfamide as a single drug for relapsed paediatric patients

M. Scopinaro, E. Schwartzman, N. Angueyra, 2004, Cancer Chemotherapy and Pharmacology.

A multicentric study of interval compressed multiagent chemotherapy and metronomic chemotherapy for patients with Ewing sarcoma family of tumors: The Latin American Pediatric Oncology Group trial

A. Petrilli, M. T. Almeida, S. Ferman, 2015 .

Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina.

G. Chantada, D. Alderete, S. Casak, 1997, Medical and pediatric oncology.

Prognostic stratification for children with hepatoblastoma: the SIOPEL experience.

B. Morland, G. Perilongo, A. Zimmermann, 2012, European journal of cancer.

Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapy.

M. Stevens, J. Merks, J. Chisholm, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improving childhood cancer care in Latin America and the Caribbean: a PAHO Childhood Cancer Working Group position statement.

S. Gupta, C. Bodkyn, A. Denburg, 2017, The Lancet. Oncology.

Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: an up-front window study in newly diagnosed children with high-risk metastatic disease.

M. Stevens, D. Orbach, P. Thiesse, 2008, European journal of cancer.

Paediatric oncology in Argentina: medical and ethical issues.

S. Casak, M. Scopinaro, 2002, The Lancet. Oncology.

Ambulatory High-dose Methotrexate Administration in Pediatric Osteosarcoma Patients at a Single Institution in Argentina

P. Zubizarreta, M. Scopinaro, W. Cacciavillano, 2017, Journal of pediatric hematology/oncology.

[Neuroblastomas treated at the Gustave-Roussy Institute from 1975 to 1979. 173 cases].

D. Sarrazin, O. Hartmann, M. Tournade, 1983, Archives francaises de pediatrie.

Revisiting the role of doxorubicin in the treatment of rhabdomyosarcoma: an up-front window study in newly diagnosed children with high-risk metastatic disease.

M. Stevens, D. Orbach, P. Thiesse, 2008, European journal of cancer.

Prognostic stratification for children with hepatoblastoma: the SIOPEL experience.

B. Morland, G. Perilongo, A. Zimmermann, 2012, European journal of cancer.